Table 3.
Design | po250 | po250+ | po300 | po350 | po350+ | po400 | po500 | po600 | po700 | po800 |
---|---|---|---|---|---|---|---|---|---|---|
Pore size(d2)/μm | 250 | 390 | 300 | 350 | 540 | 400 | 500 | 600 | 700 | 800 |
Strut size(d1)/μm | 210 | 235 | 210 | 210 | 235 | 210 | 210 | 210 | 210 | 210 |
Layer thickness(d3)/μm | 210 | 220 | 210 | 210 | 220 | 210 | 210 | 210 | 210 | 210 |
OCT image analysis(n = 5) | √ | √ | √ | √ | √ | √ | ||||
Repeatability study (n = 5) (#time = 5) | √ | |||||||||
Specific design constraint (n = 5) | √ | √ | ||||||||
Cell viability assay (n = 3) | √ | √ | √ | √ | ||||||
Cell proliferation assay (n = 5) | √ | √ | √ | √ | ||||||
Cell morphology assay (n = 3) | √ | √ | ||||||||
CYP3A4/ALB assay (n = 3) | √ | √ |
√ indicates that the design was used in the corresponding study.